ACT TV Library - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
ACT TV Library

Source: Applied Clinical Trials


Importance of Non-Interventional Studies
Nancy Dreyer, PhD, MPH, FISPe, Global Chief of Scientific Affairs, Real-World and Late Phase Research, Quintiles Outcome, outlines why non-interventional studies and comparative effectiveness studies are essential companions to randomized clinical trials.
Watch here>>

 


Restoring "Lost" Trial Data
Peter Doshi, PhD, Associate Editor BMJ, discusses the proposal on Restoring Invisible and Abandoned Trials (RIAT) to ensure complete transparency in the clinical trials data area.
Watch here>>

 


Pediatric Trials in the EU and US
Kathryn Elaine Bohannon, Principal Strategist with INC Research, explains how European and US pediatric policies be harmonized for more effective clinical trials in children?
Watch here>>

 


New Analytics Tools Measure Quality and Performance
Peter Malamis, CEO or CRO Analytics and Michael J. Howley, PA-C, PhD, Associate Clinical Profession at the LeBow College of Business, Drexel University and Chief Science Officer, CRO Analytics describe the evolution of providing a seasoned analytics and scientifically validated and reliable instruments for measuring quality.
Watch here>>

 


How the Role of the IRB is Changing
Lindsay McNair, MD, MPH, MS, Chief Medical Officer, WIRB-Copernicus IRB, describes how eConsent changes the consent process. While the regulatory role hasn't changed, but the different capabilities they need to address more complex clinical trials.
Watch here>>

 


Clinical Data Transparency
In this video, Jamie Powers, Senior Industry Consultant, SAS Center for Health Analytics and Insights, describes how SAS has been on the forefront of data transparency for clinical trials.
Watch here>>

 


Innovation in DrugDev
Hugo Stephenson, Executive Chairman, DrugDev discusses how innovation is helping improve clinical trials, and how the company is funding innovative companies and solutions. 
Watch here>>

 


Evolution of Outsourcing
Andrew Townshend, VP of Alliance Development for INC Research provides an overview of changes in the CRO industry and how the model and services have grown to address pharma's needs.
Watch here>>

 


RBM Moves from Exploring to Execution
Duncan Hall, CEO, Triumph Consultancy Services, says sponsors and CROs are starting pilots in 2014 and fine-tuning their RBM approaches to get to the costs and quality benefits.
Watch here>>

 


A "Person"-centric Change to Healthcare
Dennis A. Robbins, PhD, MPH, Director of Translational Policy & Ethics PEARL NYU, Chief Business Development Adviser CINA discusses how to get healthcare more person-centric and addressing behavior for a more improved health outlook.
Watch here>>

 


Top Trends in eTMF
Brian Mundy, eClinical Product Manager at ePharmaSolutions, says that collaboration between sponsors, CROs and sites are going to be a bigger piece of the eTMF picture.
Watch here>>

 


Choices in the ClinTech Ecosystem
In this segment, Amy Black, Associate Director, eClinical Business Solutions, Onyx Pharmaceuticals, discusses eClinical and how the acquisition of Onyx by Amgen is influencing tech purchases.
Watch here>>

 


Safety In Pediatric Trials
In this segment, Kathryn Elaine Bohannon, Principal Strategist, Pediatrics, INC Research discusses how IRBs and Data Safety Monitoring Boards examine clinical trials in children.
Watch here>>

 


Changing Role Of The Study Monitor
Penelope K. Manasco, CEO, MANA Consulting, discusses how RBM is changing the role of the study monitor and discusses the competencies site managers will need moving forward.
Watch here>>

 


eConsent’s Impact on Patients
Lindsay McNair, MD, MPH, MS, Chief Clinical Research Officer, WIRB-Copernicus IRB, describes how eConsent changes the consent process.
Watch here>>

 


The Importance of Clinical Research Sites
Christine K. Pierre, RN, President, Society for Clinical Research Sites, discusses how SCRS is growing and the initiatives it is offering for more meaningful site engagement for CROs and sponsors.
Watch here>>

 


Social Media Listening
In this video, Melissa Mottolo, Patient Strategist Associate, Genentech, discusses how the sponsor uses social media as a way to improve the patient's experience in clinical trials.
Watch here>>

 


Quality Metrics In Clinical Trials
Linda B. Sullivan, MBA, Chief Operating Officer, Metrics Champion Consortium, says FDA guidance on Quality by Design, as well as warning letters, have contributed to the demand for quality in clinical trials.
Watch here>>

 


A Report On Paul Wicks, Head of Innovation, PatientsLikeMe
In this report, Editor Lisa Henderson discusses a recent interview with Paul Wicks and the new services for pharma that PatientsLikeMe introduced at DIA. Learn more about the learning healthcare system, which features patients at the center of the new paradigm.
Watch here>>



 


Orphan Drug Development
In this segment, CEO of Prolong Pharmaceuticals, Abraham Abuchowski, discusses the challenges and opportunities in orphan drug development. Specifically, the outcomes, recruitment, and global reach necessary in drug development for smaller populations.
Watch here>>



 


Rare Disease Pipeline
In this segment, CEO of Prolong Pharmaceuticals, Abraham Abuchowski, discusses its products in clinical development in the hematology/oncology space.
Watch here>>



 


RBM Economics 101
High risk activities and high risk data are discussed by David Knepper, Head of Continuous Improvement, Forest Labs (now Actavis). Central to the focus is Risk-Based Monitoring, as well as Quality by Design built into clinical trials. 
Watch here>>



 


Patient Centricity Today
Anne Zielinski, Global Lead for the Patient Cloud at Medidata Solutions, discusses the key trends in patient-centric clinical trials, including social media and the opportunities of mHealth.
Watch here>>



 


Keys to RBM Success
Moe Alsumidiae, President and Chief Scientific Officer, Annex Clinical, breaks down the Keys to RBM success, including the growth in IT infrastructure in this sector, the need to re-define risk in the qualitative and quantitative perspectives, and the need to close the gap in the skill sets.
Watch here>>



 


Pharmacist: The Trust Factor in Patient Engagement
In this video, Moe Alsumidiae, President and Chief Scientific Officer, Annex Clinical, discusses the opportunities to leverage the trust patients have in their pharmacists, and the pros and cons of implementing clinical trials at the pharmacy level.
Watch here>>



 


Industry Trends 2014
Moe Alsumidiae, President and Chief Scientific Officer, Annex Clinical, reviews what he sees as new trends, including eConsents, Risk-Based Monitoring advanced analytical systems, and customized database integration in IT, in addition to the progress TransCelerate has made with their initiatives.
Watch here>>



 


Patient Reported Outcomes Today
Joseph Jackson, Associate Professior, Thomas Jefferson University, Program Director, Applied Health Economics and Outcomes Research Master's Degree, discusses his experiences with ePRO, the increase of the use of ePRO in clinical trials, and the use of social media and internet communications for amplifying patient voices.
Watch here>>



 


PCORI Initiatives
In this video, Joe Selby, MD, MPH, the Executive Director, Patient Centered Outcomes Research Institute (PCORI) discusses the institute's involvement in the clinical trials industry, including interest in PRO and building a better infrastructure for trials, and the goals for PCORI's National Clinical Research Network (NCRN) .
Watch here>>

 

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here